NCT03182140View on ClinicalTrials.gov

KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method

CompletedOBSERVATIONAL
Enrollment

1,134

Participants

Timeline

Start Date

July 6, 2017

Primary Completion Date

December 19, 2019

Study Completion Date

March 31, 2020

Conditions
Contraception
Interventions
DRUG

Kyleena

Kyleena - intrauterine delivery system containing 19.5 mg LNG

Trial Locations (19)

11777

ProHEALTH Care Associates, Port Jefferson

28562

Eastern Carolina Women's Center, New Bern

33414

Visions Clinical Research, Wellington

34239

Physician Care Clinical Research LLC, Sarasota

44311

Radiant Research, Akron

48604

Saginaw Valley Medical Research Group, LLC, Saginaw

77054

TMC Life Research, Houston

80228

Jennifer Grube, MD, FACOG, Lakewood

84020

Physician's Research, Draper

84062

Physician's Research Options LLC - Revere Women's Health OB/GYN Clinic, Pleasant Grove

02721

New England Center for Clinical Research Primacare Research, LLC, Fall River

08648

Lawrence OB/GYN Clinical Research, LLC, Lawrenceville

Unknown

Many locations, Multiple Locations

Many locations, Multiple Locations

Many locations, Multiple Locations

Many locations, Multiple Locations

Many locations, Multiple Locations

Many locations, Multiple Locations

Many locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY